InVivo Therapeutics Holdings Corporation
NASDAQ: NVIV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Richard M. Toselli
- Employees
- 6
- Headquarters
- Cambridge, United States
- IPO year
- 2010
- Market cap
- $995.9K
- Website
- https://www.invivotherapeutics.com
Loading NVIV…
Loading profile data…Frequently asked questions about NVIV
What does InVivo Therapeutics Holdings Corporation (NVIV) do?
InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold...
Where does NVIV trade?
InVivo Therapeutics Holdings Corporation (NVIV) trades on the NASDAQ Capital Market.
What sector is NVIV in?
InVivo Therapeutics Holdings Corporation (NVIV) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of InVivo Therapeutics Holdings Corporation?
Richard M. Toselli is the chief executive officer of InVivo Therapeutics Holdings Corporation (NVIV).
Where is InVivo Therapeutics Holdings Corporation headquartered?
InVivo Therapeutics Holdings Corporation is headquartered in United States.
Does NVIV pay a dividend?
InVivo Therapeutics Holdings Corporation (NVIV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVIV go public?
InVivo Therapeutics Holdings Corporation (NVIV) completed its initial public offering in 2010.